Glenn S Bauman

8PUBLICATIONS
17CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersPharmacogenomicsMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 23, 2023
What's to come in PSMA therapies and diagnostics: A summary of clinical trials involving PSMA radioligand-based therapeutic and/or diagnostic approaches with active recruitment.

Debra Ann Dawson, Michael Lock, David Laidley

|May 24, 2022
Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.

Adriano Basso Dias, Antonio Finelli, Glenn Bauman

|Apr 20, 2022
The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.

Alex Pozdnyakov, Roshini Kulanthaivelu, Glenn Bauman

|Jan 25, 2022
Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.

Ur Metser, Katherine Zukotynski, Victor Mak

|Jan 21, 2021
Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician's guide.

Sympascho Young, Wei Liu, Katherine Zukotynski

|Oct 04, 2017
Initial Investigation into Microbleeds and White Matter Signal Changes following Radiotherapy for Low-Grade and Benign Brain Tumors Using Ultra-High-Field MRI Techniques.

J-G Belliveau, G S Bauman, K Y Tay

Pageof 2

Frequent Collaborators

3 joint publications

Ur Metser

2 joint publications

Antonio Finelli

1 joint publications

J-G Belliveau

1 joint publications

K Y Tay